Sherif A. Nasr, MD
President, Founder and Medical Director

Dr. Nasr is a nationally recognized Hematopathologist and thought leader in high-complexity Oncology Diagnostics. His expertise in the area has made him a sought-after advisor around innovation, corporate strategy and development, and leadership in pathology and laboratory medicine.

Prior to founding siParadigm, he was the Medical Director of Quest Diagnostics (Teterboro, NJ) and Director of Specialty and Clinical Laboratories at St. Joseph’s Regional Medical Center (Paterson, NJ).

• MD: Alexandria University Faculty of Medicine (Alexandria, Egypt)
• Residency: Anatomic and Clinical Pathology, Brown University (Providence, RI)
• Fellowship: Hematopathology, Emory University (Atlanta, GA)
• Instructor: Pathology and Laboratory Medicine, Emory University
• Publications: Blood, Hematopathology, American Journal of Medicine, Cancer, American Journal of Clinical Pathology
• Memberships: College of American Pathologists (CAP), American Society of Hematology (ASH)
• Certifications: American Board Certified, Anatomic and Clinical Pathology, Hematopathology

Ahmed Badr
Chief Executive Officer

Mr. Badr has forged an exceptional career and national reputation as a technology entrepreneur and IT executive. He joined siParadigm in 2016 as Executive Vice President with a mission to transform the lab into a digital, paperless enterprise that could rapidly scale both regionally and globally. Simultaneously, he expanded the company’s R&D in data science initiatives to deliver outstanding value to customers through advanced reporting, forecasting and trend analysis.

His success in these endeavors led to his promotion into the role as Chief Executive Officer in November of 2017. Prior to joining siParadigm, Mr. Badr co-founded and served as the Chief Information Officer of two Egyptian start-ups, ITWorx and Vezeeta. ITWorx, as a software development house, served international clients in the U.S., Canada and Arabian Peninsula, while Vezeeta was named one of the Top 5 Most Successful Start-Ups in Egypt by Fortune Magazine.

• BS: Computer Science, The American University in Cairo (Cairo, Egypt)
• MSc: Dual degrees, Computer Science and Business Administration, The American University in Cairo

Jianchuan Tao, MD
Senior Hematopathologist

• Specialty: Hematopathology, Molecular Pathology
• BMED (Bachelor of Medicine): Lanzhou Medical College (Gansu Sheng, China)
• MSc: Histology, Lanzhou Medical College
• MD: West China University (Chengdu, China)
• Residency: St. Luke’s Roosevelt Hospital (New York, NY)
• Fellowship: Hematopathology, H. Lee Moffitt Cancer Center & Research Institute (Tampa, FL)
• Research: Molecular Pathology, French Institute of Health (Paris, France)
• Research: Molecular Pathology, SUNY at Stony Brook (Stony Brook, NY)
• Publications: OncoImmunology, Oncotarget
• Memberships: College of American Pathologists (CAP), American Society for Clinical Pathology (ASCP)
• Certifications: American Board Certified, Anatomic and Clinical Pathology, Hematopathology

Randa Jannoun-Nasr, PhD
Technical Director, Molecular
Supervisor, Histology

• BS: Biology and Chemistry, American University of Beirut (Beirut, Lebanon)
• MS: Biochemistry, American University of Beirut
• PhD: Cell and Molecular Genetics, St. Louis University (St. Louis, MO)
• Training: Centers for Disease Control and Prevention (Atlanta, GA), Michigan Cancer Center, Wayne State University (Detroit, MI)

Rajendra Perni, MS, MB (ASCP)^(CM)
Acting Director of Quality Assurance, Supervisor, Molecular Pathology

• BA: Pharmacy, Jawaharial Nehru Technological University (Hyderabad, Telangana, India)
• MSc: Molecular Medicine, Drexel University (Philadelphia, PA)
• Certifications: American Society for Clinical Pathology (ASCP) Certified in Molecular Biology

Saud S. Rahman, MD
Senior Hematopathologist

• Specialty: Hematopathology, Medical Directorship
• BA: Chemistry, Duke University (Durham, NC)
• MD: Wake Forest University (Winston-Salem, NC)
• Residency: Anatomic and Clinical Pathology, Virginia Commonwealth University (Richmond, VA)
• Residency: Chief Resident, Virginia Commonwealth University
• Fellowship: Hematopathology, NYU Medical Center (New York, NY)
• Publications: American Journal of Clinical Pathology, Blood
• Memberships: College of American Pathologists (CAP), American Society for Clinical Pathology (ASCP), United States and Canadian Academy of Pathology (USCAP)
• Certifications: American Board Certified, Anatomic and Clinical Pathology, Hematopathology

Bing Li, CT (ASCP)^(CM)
Executive Director of Operations

• BA: Electrical Engineering, Central-South University (Hunan, China)
• Training: Yale University School of Medicine (New Haven, CT)
• Certifications: American Society for Clinical Pathology (ASCP) Certified in Cytotechnology

Mohammad Toor, PhD, CG (ASCP)^(CM)
Technical Director, Cytogenetics

• BA/BS: [Need]
• PhD: Histology, Washington State University (Pullman, WA)
• Fellowship: Genetics, Department of Genetics, Columbia University Presbyterian Medical Center (New York, NY)
• Research: Cytogenetics, Columbia University Presbyterian Medical Center
• Training: University of Tübingen (Tübingen, Germany), University of Lund (Lund, Sweden)
• Certifications: American Society for Clinical Pathology (ASCP) Certified in Cytogenetics